Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Oct, 18 2025
Sep, 30 2025
Nov, 28 2025
Oct, 27 2025
Jan, 16 2026